Monday, February 12, 2018
During the week ending February 3, 2018, influenza activity level was categorized as geographically widespread. This is the ninth consecutive week that widespread activity has been reported. There were 15,753 laboratory-confirmed influenza reports, a 35% increase over last week. Of the 4,015 specimens submitted to WHO/NREVSS laboratories, 1,044 (26%) were positive for influenza. Of the 290 specimens tested at Wadsworth Center, 195 were positive for influenza. 31 were Influenza A (H1), 142 were influenza A (H3), 21 were influenza B (Yamagata) and 1 was influenza B (Victoria). Reports of percent of patient visits for influenza-like illness (ILI) from ILINet providers was 11.43%, which is above the regional baseline of 3.10%. The number of patients hospitalized with laboratory-confirmed influenza was 2,349 a 2% increase over last week. There were two influenza-associated pediatric deaths reported this week. There have been three influenza-associated pediatric deaths reported this season. Preliminary results for influenza vaccine effectiveness (VE) in the US have not been released for the current season, but according to the CDC, data suggests that the influenza vaccine continues to offer protection against all influenza viruses, and can reduce the severity of illness for those who do get the flu.
Information obtained from the New York State Department of Health Weekly Influenza Surveillance Report.